Security
TriSalus Life Sciences, Inc. Common Stock · TLSI
TLSINASDAQCommon stockCurrentCIK 1826667Updated Oct 8, 2026
Name history
MedTech Acquisition Corp · through Aug 10, 2023MedTech Acquisition Corporation · through Oct 29, 2020
TLSI price & chart
Loading TradingView…
NASDAQ:TLSI on TradingView ↗In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI ↗
Recent filings
4 filing
Other Events
Items 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 36,463,000Source | 27,477,000Source | 62,448,000Source | 41,317,000Source | 32,431,000Source | 70,979,000Source | 28,625,000Source | 17,889,000Source | 35,331,000Source | 23,971,000Source | 25,725,000Source | 20,187,776Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 22,687,000Source | 11,288,000Source | 46,288,000Source | 26,490,000Source | 16,481,000Source | 56,553,000Source | 13,000,000Source | 3,970,000Source | 20,439,000Source | 8,525,000Source | 11,777,000Source | 153,563Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,000,000Source | 4,912,000Source | 6,459,000Source | 5,571,000Source | 4,706,000Source | 5,215,000Source | 5,453,000Source | 4,277,000Source | 6,558,000Source | 5,087,000Source | 3,554,000Source | — |
| Inventory, NetUSD | 3,276,000Source | 3,999,000Source | 4,205,000Source | 3,807,000Source | 3,443,000Source | 3,778,000Source | 4,162,000Source | 2,913,000Source | 3,077,000Source | 4,048,000Source | 2,545,000Source | — |
| Assets, CurrentUSD | 33,328,000Source | 23,808,000Source | 59,744,000Source | 38,084,000Source | 27,941,000Source | 68,138,000Source | 25,096,000Source | 13,191,000Source | 32,244,000Source | 20,669,000Source | 20,862,000Source | 359,892Source |
| Operating Lease, Right-of-Use AssetUSD | 890,000Source | 1,427,000Source | 798,000Source | 1,103,000Source | 1,123,000Source | 830,000Source | 1,137,000Source | 1,196,000Source | 861,000Source | 1,210,000Source | 1,179,000Source | — |
| Other Assets, NoncurrentUSD | 419,000Source | 424,000Source | 69,000Source | 419,000Source | 424,000Source | 69,000Source | 424,000Source | 424,000Source | 418,000Source | 423,000Source | 466,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 63,188,000Source | 47,911,000Source | 55,898,000Source | 60,740,000Source | 56,580,000Source | 58,172,000Source | 62,995,000Source | 52,812,000Source | 69,192,000Source | 49,865,000Source | 51,663,000Source | 13,654,332Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 4,000Source | 3,000Source | 5,000Source | 3,000Source | 2,000Source | 5,000Source | 3,000Source | 2,000Source | 4,000Source | 3,000Source | 2,000Source | — |
| Additional Paid in CapitalUSD | 294,241,000Source | 249,004,000Source | 344,776,000Source | 278,786,000Source | 241,777,000Source | 341,846,000Source | 255,551,000Source | 226,671,000Source | 296,718,000Source | 253,652,000Source | 222,437,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | -320,970,000Source | -269,441,000Source | -338,231,000Source | -298,212,000Source | -265,928,000Source | -329,044,000Source | -289,924,000Source | -261,596,000Source | -330,583,000Source | -279,549,000Source | -248,377,000Source | -13,267,211Source |
| Stockholders' Equity Attributable to ParentUSD | -26,725,000Source | -20,434,000Source | 6,550,000Source | -19,423,000Source | -25,263,000Source | 12,807,000Source | -34,370,000Source | -36,037,000Source | -33,861,000Source | -25,894,000Source | -25,938,000Source | -13,266,586Source |
| Liabilities and EquityUSD | 36,463,000Source | 27,477,000Source | 62,448,000Source | 41,317,000Source | 32,431,000Source | 70,979,000Source | 28,625,000Source | 17,889,000Source | 35,331,000Source | 23,971,000Source | 25,725,000Source | 20,187,776Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 10,910,000Source | 9,918,000Source | 11,172,000Source | 9,324,000Source | 11,997,000Source | 11,786,000Source | 11,753,000Source | 14,394,000Source | 11,499,000Source | 10,228,000Source | 14,687,000Source | 2,501,998Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 128,000Source | 136,000Source | 275,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 1,186,000Source | 1,311,000Source | 1,156,000Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 6,773,000Source | 7,877,000Source | 7,107,000Source | 7,078,000Source | 9,407,000Source | 7,067,000Source | 8,403,000Source | 11,423,000Source | 8,096,000Source | 7,355,000Source | 10,556,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 32,764,000Source | 21,678,000Source | 33,065,000Source | 32,274,000Source | 21,286,000Source | 33,079,000Source | 31,699,000Source | — | 33,046,000Source | 22,084,000Source | — | — |
| Property, Plant and Equipment, Net | — | —Source | — | — | —Source | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 5,539,079Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | —Source | —Source | —Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 2,472,000Source | 1,620,000Source | 9,131,000Source | 5,441,000Source | 1,402,000Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -1,291,000Source | 366,000Source | 1,634,000Source | 1,719,000Source | 1,979,000Source | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 701,000Source | 114,000Source | -971,000Source | 1,503,000Source | 1,073,000Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,480,000Source | -4,499,000Source | -18,012,000Source | -40,843,000Source | -50,045,000Source | -2,736,994Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -141,000Source | -714,000Source | -838,000Source | -345,000Source | -2,121,000Source | 233,198,137Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 141,000Source | 754,000Source | 918,000Source | 345,000Source | 588,000Source | — |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 232,371,273Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 42,385,000Source | 9,688,000Source | 30,764,000Source | 37,936,000Source | 54,629,000Source | -230,508,464Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 35,764,000Source | 4,475,000Source | 11,914,000Source | -3,252,000Source | 2,463,000Source | -47,321Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 23,037,000Source | 11,638,000Source | 46,288,000Source | 26,840,000Source | 56,553,000Source | 13,350,000Source | 20,789,000Source | 8,875,000Source | 12,127,000Source | 153,563Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 1,140,000Source | 709,000Source | 3,697,000Source | 1,750,000Source | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 0Source | 1,000Source | 16,000Source | 18,000Source | 14,000Source | 543,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | 296,000Source | 235,000Source | 1,049,000Source | 612,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | 18,000Source | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | 600,000Source | 700,000Source | 684,000Source | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | — | — | 3,900,000Source | -835,000Source | -4,086,000Source | -2,777,000Source | -10,855,000Source | — |
| Gain (Loss) on Sale of DerivativesUSD | — | — | — | 0Source | — | — | — | — | — | 0Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -1,000Source | -117,000Source | -120,000Source | -23,000Source | -44,000Source | — |
| General and Administrative ExpenseUSD | — | — | 6,659,000Source | 4,727,000Source | 5,159,000Source | 5,910,000Source | 5,451,000Source | 5,246,000Source | 21,458,000Source | 17,966,000Source | 23,512,000Source | 2,746,125Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | 190,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 5,000Source | -3,000Source | 4,000Source | -3,000Source | 4,000Source | 5,000Source | 7,000Source | 6,000Source | 9,000Source | 570,854Source |
| InterestExpenseNonoperatingUSD | — | — | 1,460,000Source | 1,142,000Source | 1,490,000Source | 1,423,000Source | 1,436,000Source | 1,209,000Source | 5,544,000Source | 3,090,000Source | — | — |
| Investment Income, InterestUSD | — | — | 170,000Source | 158,000Source | 457,000Source | 134,000Source | 164,000Source | 74,000Source | 555,000Source | 404,000Source | 431,000Source | 3,018,726Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -10,811,000Source | -2,399,000Source | -9,187,000Source | -8,288,000Source | 1,539,000Source | -10,375,000Source | -39,227,000Source | -30,045,000Source | -59,038,000Source | 5,539,079Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -41,274,000Source | -3,202,000Source | -9,187,000Source | -9,002,000Source | 1,539,000Source | -11,087,000Source | -69,690,000Source | -33,233,000Source | -63,277,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | — | 8,856,058Source |
| Other Nonoperating Income (Expense)USD | — | — | -94,000Source | -13,000Source | 90,000Source | -40,000Source | -76,000Source | -251,000Source | -456,000Source | -312,000Source | -379,000Source | — |
| Payments for Repurchase of WarrantsUSD | — | — | — | — | — | — | — | — | — | 0Source | 20,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 42,625,000Source | 0Source | 22,000,000Source | 15,537,000Source | — | — |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | — | — | — | 82,741Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 32,000Source | 279,000Source | 510,000Source | 76,000Source | 179,000Source | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 11,566,000Source | 7,349,000Source | 11,407,000Source | 11,213,000Source | 8,899,000Source | 9,167,000Source | 45,151,000Source | 29,431,000Source | 18,511,000Source | — |
| Cost of RevenueUSD | — | — | 1,906,000Source | 1,004,000Source | 1,508,000Source | 1,802,000Source | 1,230,000Source | 1,495,000Source | 6,965,000Source | 4,103,000Source | 2,605,000Source | — |
| Operating Income (Loss)USD | — | — | -9,014,000Source | -8,739,000Source | -9,813,000Source | -7,332,000Source | -8,411,000Source | -7,329,000Source | -26,946,000Source | -36,165,000Source | -54,150,000Source | -2,746,125Source |
| Other Nonoperating Income (Expense)USD | — | — | -94,000Source | -13,000Source | 90,000Source | -40,000Source | -76,000Source | -251,000Source | -456,000Source | -312,000Source | -379,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -10,806,000Source | -2,402,000Source | -9,183,000Source | -8,291,000Source | 1,543,000Source | -10,370,000Source | -39,220,000Source | -30,039,000Source | -59,029,000Source | 6,109,933Source |
| Income Tax Expense (Benefit)USD | — | — | 5,000Source | -3,000Source | 4,000Source | -3,000Source | 4,000Source | 5,000Source | 7,000Source | 6,000Source | 9,000Source | 570,854Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -10,811,000Source | -2,399,000Source | -9,187,000Source | -8,288,000Source | 1,539,000Source | -10,375,000Source | -39,227,000Source | -30,045,000Source | -59,038,000Source | 5,539,079Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.96Source | -0.12Source | -0.16Source | -0.27Source | 0.03Source | -0.39Source | -1.84Source | -1.31Source | -6.73Source | — |
| Earnings Per Share, DilutedUSD per share | — | — | -0.96Source | -0.12Source | -0.16Source | -0.27Source | 0.03Source | -0.39Source | -1.84Source | -1.31Source | -6.73Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 43,057,632Source | 26,501,597Source | 58,296,711Source | 32,899,297Source | 51,539,682Source | 28,527,453Source | 37,897,785Source | 25,331,753Source | 9,395,748Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 43,057,632Source | 26,501,597Source | 58,296,711Source | 32,899,297Source | 52,314,410Source | 28,527,453Source | 37,897,785Source | 25,331,753Source | 9,395,748Source | — |
| Interest Expense (non-operating)USD | — | — | 1,460,000Source | 1,142,000Source | 1,490,000Source | 1,423,000Source | 1,436,000Source | 1,209,000Source | 5,544,000Source | 3,090,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | 18,000Source | — |
| Business Combination, Acquisition Related CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 40,000,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | 135,000Source | 172,000Source | 626,000Source | 744,000Source | 702,000Source | — |
| General and Administrative ExpenseUSD | — | — | 6,659,000Source | 4,727,000Source | 5,159,000Source | 5,910,000Source | 5,451,000Source | 5,246,000Source | 21,458,000Source | 17,966,000Source | 23,512,000Source | 2,746,125Source |
| Gross ProfitUSD | — | — | 9,660,000Source | 6,345,000Source | 9,899,000Source | 9,411,000Source | 7,669,000Source | 7,672,000Source | 38,186,000Source | 25,328,000Source | 15,906,000Source | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 16,000Source | — |
| Investment Income, InterestUSD | — | — | 170,000Source | 158,000Source | 457,000Source | 134,000Source | 164,000Source | 74,000Source | 555,000Source | 404,000Source | 431,000Source | 3,018,726Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -41,274,000Source | -3,202,000Source | -9,187,000Source | -9,002,000Source | 1,539,000Source | -11,087,000Source | -69,690,000Source | -33,233,000Source | -63,277,000Source | — |
| Nonoperating Income (Expense)USD | — | — | — | — | — | — | — | — | — | — | — | 8,856,058Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 0Source | 803,000Source | 0Source | 714,000Source | 0Source | 712,000Source | 0Source | 3,188,000Source | 1,258,000Source | — |
| Research and Development ExpenseUSD | — | — | 5,176,000Source | 4,219,000Source | 3,137,000Source | 3,670,000Source | 3,216,000Source | 3,021,000Source | 14,965,000Source | 17,688,000Source | 29,510,000Source | — |
| Selling and Marketing ExpenseUSD | — | — | 6,839,000Source | 6,138,000Source | 11,416,000Source | 7,163,000Source | 7,413,000Source | 6,734,000Source | 28,709,000Source | 25,839,000Source | 17,034,000Source | — |
Filing attachments
ex99-1.htm · 8-K · 2026-02-20
Exhibit 99.1 TriSalus Life Sciences Proposes Public Offering WESTMINSTER, Colo. - (BUSINESS WIRE) - February 19, 2026 - TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the s…
Read attachment ↗ex99-2.htm · 8-K · 2026-02-20
Exhibit 99.2 TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering WESTMINSTER, Colo. - (BUSINESS WIRE) - February 20, 2026 - TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced it has priced its previously announced underwritten public offering of 9,756,100 s…
Read attachment ↗